These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 11282243)
1. The role of plasma proteins in brain targeting: species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles. Gessner A; Olbrich C; Schröder W; Kayser O; Müller RH Int J Pharm; 2001 Feb; 214(1-2):87-91. PubMed ID: 11282243 [TBL] [Abstract][Full Text] [Related]
2. Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns. Göppert TM; Müller RH J Drug Target; 2005 Apr; 13(3):179-87. PubMed ID: 16036306 [TBL] [Abstract][Full Text] [Related]
3. Lipid-drug conjugate nanoparticles of the hydrophilic drug diminazene-cytotoxicity testing and mouse serum adsorption. Olbrich C; Gessner A; Schröder W; Kayser O; Müller RH J Control Release; 2004 May; 96(3):425-35. PubMed ID: 15120899 [TBL] [Abstract][Full Text] [Related]
4. Apolipoproteins adsorption and brain-targeting evaluation of baicalin nanocrystals modified by combination of Tween80 and TPGS. Liu Y; Ma Y; Xu J; Chen Y; Xie J; Yue P; Zheng Q; Yang M Colloids Surf B Biointerfaces; 2017 Dec; 160():619-627. PubMed ID: 29031222 [TBL] [Abstract][Full Text] [Related]
5. Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN). Göppert TM; Müller RH Eur J Pharm Biopharm; 2005 Aug; 60(3):361-72. PubMed ID: 15996577 [TBL] [Abstract][Full Text] [Related]
6. Drug delivery to the brain--realization by novel drug carriers. Müller RH; Keck CM J Nanosci Nanotechnol; 2004 May; 4(5):471-83. PubMed ID: 15503432 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the in vitro differential protein adsorption patterns of didanosine-loaded nanostructured lipid carriers (NLCs) for potential targeting to the brain. Kasongo KW; Jansch M; Müller RH; Walker RB J Liposome Res; 2011 Sep; 21(3):245-54. PubMed ID: 21174528 [TBL] [Abstract][Full Text] [Related]
8. Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting. Göppert TM; Müller RH Int J Pharm; 2005 Sep; 302(1-2):172-86. PubMed ID: 16098695 [TBL] [Abstract][Full Text] [Related]
9. Colloidal carriers for intravenous drug targeting: plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis. Blunk T; Hochstrasser DF; Sanchez JC; Müller BW; Müller RH Electrophoresis; 1993 Dec; 14(12):1382-7. PubMed ID: 8137807 [TBL] [Abstract][Full Text] [Related]
10. Adsorption of plasma proteins on uncoated PLGA nanoparticles. Sempf K; Arrey T; Gelperina S; Schorge T; Meyer B; Karas M; Kreuter J Eur J Pharm Biopharm; 2013 Sep; 85(1):53-60. PubMed ID: 23395970 [TBL] [Abstract][Full Text] [Related]
11. Biomimetic ApoE-Reconstituted High Density Lipoprotein Nanocarrier for Blood-Brain Barrier Penetration and Amyloid Beta-Targeting Drug Delivery. Song Q; Song H; Xu J; Huang J; Hu M; Gu X; Chen J; Zheng G; Chen H; Gao X Mol Pharm; 2016 Nov; 13(11):3976-3987. PubMed ID: 27700119 [TBL] [Abstract][Full Text] [Related]
12. Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis. Kim HR; Andrieux K; Gil S; Taverna M; Chacun H; Desmaële D; Taran F; Georgin D; Couvreur P Biomacromolecules; 2007 Mar; 8(3):793-9. PubMed ID: 17309294 [TBL] [Abstract][Full Text] [Related]
13. Comparison of protein adsorption patterns onto differently charged hydrophilic superparamagnetic iron oxide particles obtained in vitro and ex vivo. Lind K; Kresse M; Müller RH Electrophoresis; 2001 Oct; 22(16):3514-21. PubMed ID: 11669535 [TBL] [Abstract][Full Text] [Related]
14. Plasma protein adsorption of Tween 80- and poloxamer 188-stabilized solid lipid nanoparticles. Göppert TM; Müller RH J Drug Target; 2003 May; 11(4):225-31. PubMed ID: 14578109 [TBL] [Abstract][Full Text] [Related]
15. Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption. Gessner A; Waicz R; Lieske A; Paulke B; Mäder K; Müller RH Int J Pharm; 2000 Mar; 196(2):245-9. PubMed ID: 10699728 [TBL] [Abstract][Full Text] [Related]
16. Plasma protein adsorption patterns on liposomes: establishment of analytical procedure. Diederichs JE Electrophoresis; 1996 Mar; 17(3):607-11. PubMed ID: 8740186 [TBL] [Abstract][Full Text] [Related]
17. Identification of plasma proteins facilitated by enrichment on particulate surfaces: analysis by two-dimensional electrophoresis and N-terminal microsequencing. Lück M; Schröder W; Harnisch S; Thode K; Blunk T; Paulke BR; Kresse M; Müller RH Electrophoresis; 1997 Dec; 18(15):2961-7. PubMed ID: 9504836 [TBL] [Abstract][Full Text] [Related]
18. Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and Protein Lab-on-chip system. Kim HR; Andrieux K; Delomenie C; Chacun H; Appel M; Desmaële D; Taran F; Georgin D; Couvreur P; Taverna M Electrophoresis; 2007 Jul; 28(13):2252-61. PubMed ID: 17557357 [TBL] [Abstract][Full Text] [Related]
19. Effects of apolipoproteins on dalargin transport across the blood-brain barrier. Shamenkov DA; Petrov VE; Alyautdin RN Bull Exp Biol Med; 2006 Dec; 142(6):703-6. PubMed ID: 17603675 [TBL] [Abstract][Full Text] [Related]